A comprehensive clinically informed map of dependencies in cancer cells and framework for target prioritization
Authors:
Top Cited Papers
Open Access
- 11 January 2024
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 42 (2) , 301-316.e9
Abstract
No abstract availableKeywords
Funding Information
- National Institute on Drug Abuse
- National Heart, Lung, and Blood Institute
- National Institutes of Health
- National Human Genome Research Institute
- National Cancer Institute
- National Institute of Neurological Disorders and Stroke
- National Institute of Mental Health
- Wellcome Trust (206194)
This publication has 61 references indexed in Scilit:
- A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal TransitionClinical Cancer Research, 2016
- Genefu: an R/Bioconductor package for computation of gene expression-based signatures in breast cancerBioinformatics, 2015
- The consensus molecular subtypes of colorectal cancerNature Medicine, 2015
- The support of human genetic evidence for approved drug indicationsNature Genetics, 2015
- Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexesNature Genetics, 2014
- Loss of Lkb1 and Pten Leads to Lung Squamous Cell Carcinoma with Elevated PD-L1 ExpressionCancer Cell, 2014
- Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular SubtypesClinical Cancer Research, 2008
- KEGG for linking genomes to life and the environmentNucleic Acids Research, 2007
- Adjusting batch effects in microarray expression data using empirical Bayes methodsBiostatistics, 2006
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001